96 related articles for article (PubMed ID: 7720986)
1. [Treatment of acute chemically induced diarrhea by inhibition of enkephalinase. Results of a pilot study].
Dorval ED; Regimbeau C; Gamelin E; Picon L; Bérard H
Gastroenterol Clin Biol; 1995 Jan; 19(1):27-30. PubMed ID: 7720986
[TBL] [Abstract][Full Text] [Related]
2. Effects of acetorphan, an enkephalinase inhibitor, on experimental and acute diarrhoea.
Baumer P; Danquechin Dorval E; Bertrand J; Vetel JM; Schwartz JC; Lecomte JM
Gut; 1992 Jun; 33(6):753-8. PubMed ID: 1624154
[TBL] [Abstract][Full Text] [Related]
3. The enkephalinase inhibitor, acetorphan, in acute diarrhoea. A double-blind, controlled clinical trial versus loperamide.
Roge J; Baumer P; Berard H; Schwartz JC; Lecomte JM
Scand J Gastroenterol; 1993 Apr; 28(4):352-4. PubMed ID: 8488368
[TBL] [Abstract][Full Text] [Related]
4. Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study.
Beaugerie L; Baumer P; Chaussade S; Berard H; Rozenbaum W; Pialoux G; Le Quintrec Y; Schwartz JC; Lecomte JM
Eur J Gastroenterol Hepatol; 1996 May; 8(5):485-9. PubMed ID: 8804878
[TBL] [Abstract][Full Text] [Related]
5. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
[TBL] [Abstract][Full Text] [Related]
6. [Action of acetorphan, an enkephalinase inhibitor, in acute diarrhea].
Baumer P; Danquechin Dorval E; Bertrand J; Vetel JM; Schwartz JC; Lecomte JM
Ann Gastroenterol Hepatol (Paris); 1992; 28(6-7):279-85. PubMed ID: 1285638
[No Abstract] [Full Text] [Related]
7. Racecadotril in the treatment of acute watery diarrhea in children.
Salazar-Lindo E; Santisteban-Ponce J; Chea-Woo E; Gutierrez M
N Engl J Med; 2000 Aug; 343(7):463-7. PubMed ID: 10944563
[TBL] [Abstract][Full Text] [Related]
8. Octreotide (SMS 201-995) for hematopoietic support-dependent high-dose chemotherapy (HSD-HDC)-related diarrhoea: dose finding study and evaluation of efficacy.
Wasserman E; Hidalgo M; Hornedo J; Cortés-Funes H
Bone Marrow Transplant; 1997 Nov; 20(9):711-4. PubMed ID: 9384471
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
10. Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study.
François E; Berdah JF; Chamorey E; Lesbats G; Teissier E; Codoul JF; Badetti JL; Hébert C; Mari V
Cancer Chemother Pharmacol; 2008 Nov; 62(6):931-6. PubMed ID: 18273618
[TBL] [Abstract][Full Text] [Related]
11. Weekly high-dose 5-fluorouracil as a 24-h infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with locally advanced nonresectable and metastatic adenocarcinoma or squamous cell carcinoma of the oesophagus: a phase II trial.
Wolff K; Wein A; Reulbach U; Männlein G; Brückl V; Meier C; Ostermeier N; Schwab SA; Horbach T; Hohenberger W; Hahn EG; Boxberger F
Anticancer Drugs; 2009 Mar; 20(3):165-73. PubMed ID: 19125117
[TBL] [Abstract][Full Text] [Related]
12. Introduction. Enkephalinase inhibition: a rational approach to antisecretory therapy for acute diarrhoea.
Farthing MJ
Aliment Pharmacol Ther; 1999 Dec; 13 Suppl 6():1-2. PubMed ID: 10646044
[No Abstract] [Full Text] [Related]
13. Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC).
Link K; Happich K; Schirner I; Jüngert B; Brückl V; Männlein G; Brückl WM; Merkel S; Göhl J; Hohenberger W; Hahn EG; Wein A
Anticancer Res; 2004; 24(1):385-91. PubMed ID: 15015625
[TBL] [Abstract][Full Text] [Related]
14. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment.
Saliba F; Hagipantelli R; Misset JL; Bastian G; Vassal G; Bonnay M; Herait P; Cote C; Mahjoubi M; Mignard D; Cvitkovic E
J Clin Oncol; 1998 Aug; 16(8):2745-51. PubMed ID: 9704727
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
[TBL] [Abstract][Full Text] [Related]
17. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
[TBL] [Abstract][Full Text] [Related]
18. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
Kemeny N; Garay CA; Gurtler J; Hochster H; Kennedy P; Benson A; Brandt DS; Polikoff J; Wertheim M; Shumaker G; Hallman D; Burger B; Gupta S
J Clin Oncol; 2004 Dec; 22(23):4753-61. PubMed ID: 15570076
[TBL] [Abstract][Full Text] [Related]
19. Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer.
Chau I; Webb A; Cunningham D; Hill M; Waters JS; Norman A; Massey A
Br J Cancer; 2001 Nov; 85(9):1258-64. PubMed ID: 11720458
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of racecadotril and single dose octreotide as an anti-secretory agent in acute infective diarrhoea.
Mehta S; Khandelwal PD; Jain VK; Sihag M
J Assoc Physicians India; 2012 Nov; 60():12-5. PubMed ID: 23767196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
